Handbook of Regenerative Medicine : Cell-Free Therapy Approach (Hardcover)

Chapter 1: Extracellular Vesicles as Therapeutic Agents in Dentistry from Laboratory to Clinic. Chapter 2: Extracellular Vesicles-Based Cell-Free Therapies in Cardiovascular Diseases. Chapter 3: Regenerative therapy with extracellular vesicles in acute and chronic kidney injury. Chapter 4: Isolation and characterization of IPSC EVs preconditioned with severe critically ill COVID-19 patient’s serum. Chapter 5: Therapeutic Efficacy of Mesenchymal Stem Cells and their Derived Exosomes in Different Neurodegenerative Disorders: Current Status and Future Perspectives. Chapter 6: Applications and Implications of Mesenchymal Stem Cell-Derived Exosomes in Ophthalmology. Chapter 7: Future management of type 2 diabetes and its complications by Mesenchymal Stem Cell-derived Exosomes (MSC-Exos). Chapter 8: Liquid biopsy biomarkers for personalized management in heart failure. Chapter 9: Prospective Implications of Autologous Platelet-Rich Plasma in Tissue Engineering and Organ Rejuvenation. Chapter 10: Cell-free and Cell-based Therapy in Regenerative Medicine. Chapter 11: Mesenchymal Cell-free and Cell-based Therapy in regenerative medicine: moving toward formulation, GMP-production, regulatory approval, and market access. Chapter 12: Unveiling mesenchymal stem cells secretome potentials in regenerative medicine and disease therapeutics. Chapter 13: Engineering Therapeutic Mesenchymal Stem Cells Secretome for Bone Regeneration. Chapter 14: Cell-free scaffolding, a Tissue-Engineering approach with the potential to revolutionize the regeneration of Chondral tissue. Chapter 15: The secretome of mesenchymal stromal cells in treating intracerebral hemorrhage: our experience. Chapter 16: Stem Cell Secretome as Theranostics for Traumatic Brain Injury. Chapter 17: Cell-free and Cell-based Therapies in Regenerative Medicine. Chapter 18: Mesenchymal stem cell secretomes for cell-free therapy of the broken heart. Chapter 19: From 2D to 3D and Cellular to Cell-free: Evolutions in strategies for regenerative medicine. Chapter 20: Cell-free and Cell-Based Approaches in Neurological Surgery. Chapter 21: Cell-free and Cell-based Therapies in Regenerative Medicine. Chapter 22: Autologous versus Allogenic Mesenchymal Stem Cells in Heart Disease: Revisiting Preclinical and Clinical Trials. Chapter 23: Exosomes and Encapsulated ExomiRs in Breast Cancer: Theranostic Applications and Clinical Implications. Chapter 24: The Potential of Mesenchymal Stem Cell-Derived Exosomes in Cell-Free Therapy for Myocardial Repair. Chapter 25: Theragnostic applications of exosomes in Alzheimer's Disease.